Skip to content

The effects of Geotherapy on Heartburn and Reflux Symptoms: pilot clinical trial

The Effects of Geotherapy on the symtoms of Gastroesophageal Reflux disease: pilot clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
REBEC
Registry ID
RBR-44np8k
Enrollment
Unknown
Registered
2019-06-21
Start date
2018-10-07
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heartburn, peptic esophagiti

Interventions

The intervention will be performed with the application of the yellow clay (cataplasm modality) in the epigastric region during 40 minutes, will be 9 participants, to receive the cataplasm the individ
Other
E02.190

Sponsors

Unisul
Lead Sponsor
Unisul
Collaborator

Eligibility

Age
21 Years to 70 Years

Inclusion criteria

Inclusion criteria: Be at least 21 years of age; Have a diagnosis of gastroesophageal reflux; Be willing to attend the sessions of the research protocol in full; Know how to read and write;

Exclusion criteria

Exclusion criteria: Present lesions on the skin in the region where the clay poultice will be applied; Patients undergoing recent gastroesophageal surgery (time less than 30 days), who present a surgical incision in the healing process and still under the effect of post-surgical drug therapy (analgesics, antipyretic and antiemetic); Use of topical medications in the region that compromise the application of epigastric cataplasm.

Design outcomes

Primary

MeasureTime frame
To evaluate improvement in pain relief and symptom relief in gastroesophageal reflux disease with yellow clay epigastric cataplasm.

Secondary

MeasureTime frame
Decreased pain and symptoms in GERD with application of epigastric yellow clay cataplasm. It was evaluated by three questionnaires (QS-GERD, EVA and Sociodemographic) Data collected during the intervention and after one month of the intervention. The p-value relative to the first and the sixth version of the poultice program was 0.002 and the p-value relative to a first alation before the poultice in relation to a sixth posterior application of the poultice was 0.001

Countries

Brazil

Contacts

Public ContactUnisul Unisul

Unisul

exchange.officefp@unisul.br(48) 3279 1000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)